Page tree
Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 21 Next »

Project Scope

Impact assessment of the estimands framework and recommendations/best practices (where applicable) for implementing the framework in the following areas:

  • Data Collect Design/CDASH
  • SDTM
  • ADaM (including handling of intercurrent events, missing data imputation) – Analysis Displays
  • cSDRG and ADRG

Development of new standards is not in scope, and any impact findings that may necessitate new standard development will be shared with CDISC for their consideration. Examples may be created on how to implement the framework by using permitted extensions to the existing data standards.

Project LeadsEmail
Chris Price

chris.price.cp1@roche.com

Lori VanMeterlvanmet@ITS.JNJ.com
Katie Warren (PHUSE Project Assistant)

katie@phuse.global.

Objectives & DeliverablesTimelines

Kick off

Q1 2022

Review current company practices 

Q1 2022

Develop conference abstract 

Q2 2022

Draft paper

Q3 2022 

Conference slides 

Q4 2022

Final paper for public review

Q4 2022

Final paper published

Q1 2023

CURRENT STATUS

Project approved Q1 2022
Project MembersOrganisation 
Arman SabbaghiPurdue University
Armin SchuelerMerckgroup 
Bess LeroyCDISC
Cedric Davister Merck
Elena PolverejanJanssen Research & Development 
John ScottFDA
Junxiang LuoModerna 
Kim Musgrave Amgen
Liping SunFDA
Lisa LinFDA
Kevin Liu Pfizer 
Marc Walton Janssen Research & Development 
Ann M Pennington Pfizer 
Rama Empati AstraZeneca
Robin WhiteEli Lilly and Company
Rosanne LaneJanssen Research & Development 
Santosh K Lingala Gilead 
Shahida Tamboli Labcorp 
Stephen Ruberg Analytix Thinking
Steve Gilbert Pfizer 
Steve WilsonFDA
Yongming QuEli Lilly and Company 
  • No labels